A practical guide for the generation of model-based virtual clinical trials
Morgan Craig1,2, Jana L Gevertz3, Irina Kareva4
1Department of Mathematics and Statistics, Université de Montréal, Montréal, QC, Canada.
Frontiers in Systems Biology
|August 14, 2025
Summary
This guide details creating virtual patients using mathematical models for virtual clinical trials. It covers model design, parameter estimation, and cohort creation to advance population-based analysis.
Area of Science:
- Pharmacometrics and computational biology.
- Application of mathematical modeling in drug development.
Background:
- Mathematical modeling is crucial for drug design, development, and optimization.
- Virtual clinical trials are gaining traction for exploring patient heterogeneity.
Purpose of the Study:
- To provide best practices for creating virtual patients from mathematical models.
- To guide the implementation and execution of virtual clinical trials.
- To promote the use of virtual population-based analysis.
Main Methods:
- Discussing and providing examples of model design.
- Detailing parameter estimation and sensitivity analysis.
- Explaining model identifiability and virtual patient cohort creation.
Main Results:
- A practical framework for building virtual patient cohorts.
- Methodologies for ensuring model robustness and reliability.
- Demonstration of applying these methods in virtual clinical trial contexts.
Conclusions:
- Researchers can adopt these best practices for robust virtual clinical trials.
- Enhanced virtual population-based analysis can accelerate drug development.
- This approach facilitates a deeper understanding of therapeutic responses in diverse populations.
Related Concept Videos
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Clinical Trials
8.3K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.3K
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Statistical Software for Data Analysis and Clinical Trials
788
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
788
Pharmacokinetic Models: Overview
1.1K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.1K


